These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27809934)

  • 1. Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey.
    Karacaer Z; Cakir B; Erdem H; Ugurlu K; Durmus G; Ince NK; Ozturk C; Hasbun R; Batirel A; Yilmaz EM; Bozkurt I; Sunbul M; Aynioglu A; Atilla A; Erbay A; Inci A; Kader C; Tigen ET; Karaahmetoglu G; Coskuner SA; Dik E; Tarakci H; Tosun S; Korkmaz F; Kolgelier S; Karadag FY; Erol S; Turker K; Necan C; Sahin AM; Ergen P; Iskender G; Korkmaz P; Eroglu EG; Durdu Y; Ulug M; Deniz SS; Koc F; Alpat SN; Oztoprak N; Evirgen O; Sozen H; Dogan M; Kaya S; Kaya S; Altindis M; Aslan E; Tekin R; Sezer BE; Ozdemir K; Ersoz G; Sahin A; Celik I; Aydin E; Bastug A; Harman R; Ozkaya HD; Parlak E; Yavuz I; Sacar S; Comoglu S; Yenilmez E; Sirmatel F; Balkan II; Alpay Y; Hatipoglu M; Denk A; Senol G; Bitirgen M; Geyik MF; Guner R; Kadanali A; Karakas A; Namiduru M; Udurgucu H; Boluktas RP; Karagoz E; Ormeci N
    Health Qual Life Outcomes; 2016 Nov; 14(1):153. PubMed ID: 27809934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0.
    Spiegel BM; Bolus R; Han S; Tong M; Esrailian E; Talley J; Tran T; Smith J; Karsan HA; Durazo F; Bacon B; Martin P; Younossi Z; Hwa-Ong S; Kanwal F
    Hepatology; 2007 Jul; 46(1):113-21. PubMed ID: 17596882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection.
    Habersetzer F; Moenne-Loccoz R; Meyer N; Schvoerer E; Simo-Noumbissie P; Dritsas S; Baumert TF; Doffoël M
    Liver Int; 2015 Jan; 35(1):130-9. PubMed ID: 25145784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B.
    Sayan M; Akhan SC
    Int J Infect Dis; 2011 Oct; 15(10):e722-6. PubMed ID: 21784687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
    Li J; Sun X; Fang J; Wang C; Han G; Ren W
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical value of health-related quality of life evaluation in community patients with hepatitis B].
    Chen P; Zhu JW; Chen T; Wang DF; Yang LP; Ruan B; Yu CB; Li LJ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):313-316. PubMed ID: 28494556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life (HRQoL) and health state utilities with chronic hepatitis-B (CHB): A population-based survey in Vietnam.
    Tran QV; Vo TQ
    J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S80-S86. PubMed ID: 31369538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].
    Ji FZ; Wang L; Yang BH; Zhao JJ; Liu F; Xue Y; Li T
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):280-4. PubMed ID: 22964149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there an association between Health Related Quality of Life, socio-demographic status and Fatigue in Patients with Chronic Hepatitis B?
    Saffari M; Pakpour AH; Al Zaben F; Koenig HG
    Acta Gastroenterol Belg; 2017; 80(2):229-236. PubMed ID: 29560687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virologic response to therapy increases health-related quality of life for patients with chronic hepatitis B.
    Kim JH; Kwon SY; Lee YS; Lee JH; Lee YS; Lee CH
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):291-6. PubMed ID: 22019793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti‑viral treatment.
    Ruan P; Zhou B; Dai X; Sun Z; Guo X; Huang J; Gong Z
    Mol Med Rep; 2014 Apr; 9(4):1135-41. PubMed ID: 24566465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiviral nucleotide-induced dynamic change of HBV DNA and HBsAg and significance of quarterly and annual quantitative measurements over 5-year follow-up of chronic hepatitis B patients].
    Xi HL; Li MR; Bao Y; Yu M; Qin XQ; Xu XY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):821-4. PubMed ID: 24331690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls.
    Zhuang G; Zhang M; Liu Y; Guo Y; Wu Q; Zhou K; Ji Z; Zhang X
    Health Qual Life Outcomes; 2014 Jun; 12():101. PubMed ID: 24928466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life of Southern Chinese with chronic hepatitis B infection.
    Lam ET; Lam CL; Lai CL; Yuen MF; Fong DY; So TM
    Health Qual Life Outcomes; 2009 Jun; 7():52. PubMed ID: 19500349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B.
    Liu Y; Zhang S; Zhao Y; Du J; Jin G; Shao S; Lu X
    PLoS One; 2016; 11(9):e0162763. PubMed ID: 27631983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China.
    Toy M; Salomon JA; Jiang H; Gui H; Wang H; Wang J; Richardus JH; Xie Q
    Hepatology; 2014 Jul; 60(1):46-55. PubMed ID: 24990105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection.
    Brunetto MR; Cavallone D; Oliveri F; Moriconi F; Colombatto P; Coco B; Ciccorossi P; Rastelli C; Romagnoli V; Cherubini B; Teilum MW; Blondal T; Bonino F
    PLoS One; 2014; 9(10):e110782. PubMed ID: 25350115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
    Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
    Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health state utilities and quality of life in patients with hepatitis B.
    Woo G; Tomlinson G; Yim C; Lilly L; Therapondos G; Wong DK; Ungar WJ; Einarson TR; Sherman M; Heathcote JE; Krahn M
    Can J Gastroenterol; 2012 Jul; 26(7):445-51. PubMed ID: 22803020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study.
    Marcellin P; Arama V; Leblebicioglu H; Zarski JP; Zeuzem S; Mauss S; Sieklucki J; Acalovschi M; Usluer G; Klauck I; Morais E; Bjork S; Lescrauwaet B; Kamar D; Simon K;
    Antivir Ther; 2014; 19(3):235-43. PubMed ID: 23574686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.